Page last updated: 2024-09-04

angelmicin b and Leukemia, Myeloid

angelmicin b has been researched along with Leukemia, Myeloid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Honma, Y; Okabe-Kado, J; Oki, T; Tomoyasu, S; Tsuruoka, N; Uehara, Y; Yokoyama, A	1

Other Studies

1 other study(ies) available for angelmicin b and Leukemia, Myeloid

Article	Year
Angelmicin B, a new inhibitor of oncogenic signal transduction, inhibits growth and induces myelomonocytic differentiation of human myeloid leukemia HL-60 cells. Leukemia research, 1996, Volume: 20, Issue:6 Topics: Animals; Anthraquinones; Antibiotics, Antineoplastic; Cell Differentiation; Cell Division; Cholecalciferol; HL-60 Cells; Humans; Leukemia, Myeloid; Mice; Monocytes; Nitroblue Tetrazolium; Oncogenes; Protein-Tyrosine Kinases; Signal Transduction; Tretinoin; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	1996

Article

Year

Angelmicin B, a new inhibitor of oncogenic signal transduction, inhibits growth and induces myelomonocytic differentiation of human myeloid leukemia HL-60 cells.

Leukemia research, 1996, Volume: 20, Issue:6

Topics: Animals; Anthraquinones; Antibiotics, Antineoplastic; Cell Differentiation; Cell Division; Cholecalciferol; HL-60 Cells; Humans; Leukemia, Myeloid; Mice; Monocytes; Nitroblue Tetrazolium; Oncogenes; Protein-Tyrosine Kinases; Signal Transduction; Tretinoin; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1996